Califf: Not Wise To Create Problems Related to Chinese Pharma Supply Chain Dependence
Executive Summary
The US FDA Commissioner pushed for rebalancing the US’s pharmaceutical supply chains while also stressing that US-China commerce has a role that would be risky to compromise.